| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $631K | -18.7% |
| SG&A Expense | $614K | -16.2% |
| Operating Income | -$1.2M | +17.5% |
| Net Income | -$1.3M | +15.8% |
| EPS (Basic) | $0.07 | -12.5% |
| EPS (Diluted) | $0.07 | -12.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $2K | +0.0% |
| Current Assets | $51K | +104.0% |
| Total Assets | $53K | +96.3% |
| Current Liabilities | $1.5M | +93.2% |
| Stockholders' Equity | -$1.4M | -93.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$210K | +60.5% |
| Financing Cash Flow | $236K | -26.5% |